The Kentucky Society of Clinical Oncology focuses on providing our members with the most up to date information regarding patient care and practice management.
"... Through its screening program, St. Elizabeth has diagnosed its 500th case, marking a momentous achievement in the fight against this previously silent killer." Read more...
lanereport.com/165618/2023/0…
"Biomarker testing is a key tool in lung cancer treatment, and smoking-related lung cancer remains common in states such as Kentucky and Tennessee..." ajmc.com/view/dr-davey-danie…
Communities of color and rural America are disproportionately impacted by cancer. The re-introduced Nancy Gardner Sewell Medicare MCED Screening Coverage Act creates a pathway for Medicare to cover #MCED tests, and close existing health inequity gaps. sewell.house.gov/press-relea….
Expanding access to biomarker testing will ensure KY patients can get the right treatment at the right time. Thank you Rep. @5boymom for your work on #HB180 and to the members of the House Health Services Committee for moving the legislation to the full #KYHouse! #kyga23
Significantly, Kentucky is a leader in lung cancer statewide initiatives such as the KY LEADS Collaborative, the KY Health Collaborative, the Kentucky Cancer Consortium, and the KY Cancer Program. Read more! bluetoad.com/publication/?m=…
We had a great meeting with @ACSCANKY and @RepGuthrie today about the #Medicare Multi-Cancer #earlydetection Screening Coverage Act. This legislation is key to end late-stage cancer & save lives. Thank you, Rep. Guthrie, for making #MCED a top priority!
Join us! Tomorrow morning, Katie Barrett, BSN & Jennifer Mulholland, BSN, with St. Elizabeth Healthcare, will discuss the role of oncology nurse navigators and clinical pathways to decrease the time to treatment for lung cancer patients. Register Now! ow.ly/yPWV50LIsz4
Join us! Tomorrow morning, Bradley Gibson, M.D., Pathologist and Immunohistochemistry Director at Pathology and Cytology Labs, Lexington, KY, will discuss the post-diagnostic therapeutic testing for NSCLC. Register Now! ow.ly/EARe50LIsUb
Join us! Tomorrow morning, Neal Dunlap, MD, will discuss the role of stereotactic body radiation therapy (SBRT) in the management of early stage NSCLC and how SBRT can be integrated into immunotherapy management strategies. Register Now! ow.ly/WfSq50LIsi5
Join us! Tomorrow morning, Jason Chesney, M.D., Ph.D., will discuss the mechanism of action of TILs in NSCLC patients and brief attendees on the criteria for enrollment of NSCLC patients in TIL clinical trials. Register Now! ow.ly/h5iN50LIs53
#earlydetection is key to beating cancer. The Multi-Cancer Early Detection Screening Act has broad bipartisan support & will help seniors access the latest cancer screening tools. @LeaderMcConnell
Join tomorrow! 2022 ACS CAN Kentucky Coffee Club: Lung Cancer: Screenings, Biomarkers, and New Technologies at 9 a.m. EST, 11/16.
When you are ready to join the meeting, please join us via acscan.windrosemedia.com
#Mirvetuximab soravtansine-gynx now @FDAOncology approved for FRα +ve, plat-resistant epithelial ovarian, Fallopian tube, or 1° peritoneal Ca post 1-3L of Rx.
- Assay-Ventana FOLR1 (FOLR-2.1)
- #SORAYA: Ph3, n=106, ORR 31.7%, CR:4.8%, mDOR of 6.9 mos
#MedTwitter#OncEd#Gynsm
REMINDER: Join us on Oct. 28 to hear Dr. Radhakrishnan, PhD, discuss “Modeling the Physical Biology of Cancer Engineering at Molecular and Tissue Scales.”
9:00 AM EDT | 6:30 PM IST | UTC- 4:00
To register: tinyurl.com/GCCRavi
For more information: erinjoakley@uky.edu
ATTN: @NCCN updated the designation of our cancer treatment to Preferred Regimen in its Clinical Practice Guidelines in Oncology. Read more here: bit.ly/3IilAJ8